Top compounds associated with response to MCTS1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.6
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA WZ3105 GDSC1000 pan-cancer AAC 0.014 0.6
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA Vandetanib CCLE pan-cancer AAC -0.022 0.6
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.017 0.6
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.018 0.6
mRNA regorafenib CTRPv2 pan-cancer AAC -0.018 0.6
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC -0.035 0.6
mRNA CHIR-99021 CTRPv2 pan-cancer AAC 0.016 0.6
Download CSV